$TOI

Chernett Jorey purchased $88K of TOI

Chernett Jorey purchased 15,000 shares of Oncology Institute, Inc. (TOI) at $5.85 on 2026-07-10.

Original reporting
SEC EDGAR · Chernett Jorey
Published Jul 13, 2026, 3:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 13, 2026, 3:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TOI
Bullish
low confidence
Mentioned
$TOI
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TOIBullishLow
01

Why it matters

The newest fact is the confirmed open-market purchase by a 10% owner at a stated price, with no pre-arranged 10b5-1 plan.

02

Market read

Traders may view the purchase as a small positive sentiment signal, but there is no new operational or financial information to reprice the business materially.

03

What to watch

The article does not state whether the insider’s broader buying/selling pattern is accelerating, nor does it provide any link to upcoming catalysts or performance changes.

Relevance 4/10Novelty 5/10Timing: Filed 2026-07-13, covering a purchase executed 2026-07-10.

Background

The article is an SEC Form 4 insider transaction disclosure for Oncology Institute, Inc. (TOI).

Company-level read

Ticker impact

$TOIBullishLow confidence
Context

On 2026-07-10, 10% owner Chernett Jorey bought 15,000 shares of Oncology Institute at $5.8500, totaling $87,750, per Form 4.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-driven and small.

Evidence & confidence

The filing is primary-source and confirms insider buying, but the transaction size ($87.75k) and lack of accompanying company-specific news limit tradable signal strength.

Market effects

No sector read-across is provided; this is company-specific insider activity only.

None indicated.

None indicated.

Counterpoint

Insider buys can be discretionary and may reflect diversification or liquidity needs rather than a strong forward view.

Key entities

  • Oncology Institute, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Chernett Jorey

    10% owner who purchased 15,000 shares on 2026-07-10.

Related articles

$CNIMedAI 9/10

Canadian Stocks to Buy Today and Hold for the Next 7 Years

The article highlights three Canadian stocks for a 7-year hold: Canadian National Railway (CNR), Alimentation Couche-Tard (ATD), and Topicus.com (TOI). CNR reported Q1 revenue of $4.4B and free cash flow of $900M (+44% YoY) and repurchased $869M of shares. ATD’s fiscal Q3 adjusted EPS rose 19.1% to US$0.81; merchandise and service revenue grew 8.7% to US$5.8B. Topicus reported Q1 2026 revenue up 23% to €435.7M and free cash flow to shareholders up 2% to €165.4M.